ES2151476T3 - Formulaciones de farmacos en aerosol. - Google Patents

Formulaciones de farmacos en aerosol.

Info

Publication number
ES2151476T3
ES2151476T3 ES91912299T ES91912299T ES2151476T3 ES 2151476 T3 ES2151476 T3 ES 2151476T3 ES 91912299 T ES91912299 T ES 91912299T ES 91912299 T ES91912299 T ES 91912299T ES 2151476 T3 ES2151476 T3 ES 2151476T3
Authority
ES
Spain
Prior art keywords
aerosol
formulations
pharmacos
tetrafluoroethane
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912299T
Other languages
English (en)
Inventor
Keith A Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/649,405 external-priority patent/US5126123A/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ES2151476T3 publication Critical patent/ES2151476T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTAN FORMULACIONES PARA AEROSOL QUE COMPRENDEN UNA DROGA DE INHALACION, 1,1,1,2-TETRAFLUOROETANO (P134A) Y UN AGENTE ACTIVO DE SUPERFICIE SOLUBLE EN 1,1,1,2-TETRAFLUOROETANO.
ES91912299T 1990-06-28 1991-06-27 Formulaciones de farmacos en aerosol. Expired - Lifetime ES2151476T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54543790A 1990-06-28 1990-06-28
US07/649,405 US5126123A (en) 1990-06-28 1991-02-01 Aerosol drug formulations

Publications (1)

Publication Number Publication Date
ES2151476T3 true ES2151476T3 (es) 2001-01-01

Family

ID=27067939

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912299T Expired - Lifetime ES2151476T3 (es) 1990-06-28 1991-06-27 Formulaciones de farmacos en aerosol.

Country Status (13)

Country Link
EP (1) EP0536250B1 (es)
JP (1) JP3056784B2 (es)
AT (1) ATE196076T1 (es)
AU (1) AU649702B2 (es)
CA (1) CA2083821A1 (es)
DE (1) DE69132407T2 (es)
ES (1) ES2151476T3 (es)
GB (1) GB2263064B (es)
IE (1) IE912246A1 (es)
IL (1) IL98639A0 (es)
NZ (1) NZ238749A (es)
PT (1) PT98105B (es)
WO (1) WO1992000107A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
EP0518601A1 (en) 1991-06-10 1992-12-16 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
GB9202522D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
EP0731688B1 (en) * 1993-12-02 2003-03-05 Abbott Laboratories Aerosol drug formulations for use with non-cfc propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9626960D0 (en) 1996-12-27 1997-02-12 Glaxo Group Ltd Valve for aerosol container
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ATE320795T1 (de) * 2001-08-03 2006-04-15 Glaxo Group Ltd Oberflächenaktive verbindungen und ihre anwendungen
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
MX2007014531A (es) 2005-05-18 2008-04-29 Nektar Therapeutics Valvulas, dispositivos y metodos para terapia endobronquial.
BRPI0616642A2 (pt) 2005-09-29 2011-06-28 Nektar Therapeutics formulações de antibióticos, doses unitárias, kits e métodos
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
WO2010033240A2 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
US20210244896A1 (en) * 2018-06-13 2021-08-12 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
WO1991014422A1 (en) * 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
FR2660297B1 (fr) * 1990-03-30 1992-06-12 Coflexip Dispositif de suspension et dispositif de liaison comportant un tel dispositif de suspension.
WO1992000062A1 (en) * 1990-06-27 1992-01-09 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations

Also Published As

Publication number Publication date
JP3056784B2 (ja) 2000-06-26
GB9223891D0 (en) 1993-04-21
EP0536250A4 (en) 1993-06-16
GB2263064A (en) 1993-07-14
IE912246A1 (en) 1992-01-01
WO1992000107A1 (en) 1992-01-09
AU649702B2 (en) 1994-06-02
DE69132407T2 (de) 2001-04-05
PT98105B (pt) 1998-11-30
DE69132407D1 (de) 2000-10-12
CA2083821A1 (en) 1991-12-29
PT98105A (pt) 1993-08-31
JPH05507935A (ja) 1993-11-11
ATE196076T1 (de) 2000-09-15
EP0536250B1 (en) 2000-09-06
EP0536250A1 (en) 1993-04-14
NZ238749A (en) 1993-07-27
GB2263064B (en) 1994-09-14
AU8213591A (en) 1992-01-23
IL98639A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
ES2151476T3 (es) Formulaciones de farmacos en aerosol.
EP0995434A3 (en) Medicinal aerosol formulations
IL77467A (en) Drug-containing aerosol formulations comprising chlorofluorocarbon propellent
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
NZ238739A (en) Aerosol formulations comprising a powdered drug, a hydrofluorocarbon propellant and a perfluoroalkylsulphonamidoalkylphosphate surface-active agent
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
EP0636362A3 (en) Use of soluble fluorinated surfactants in the preparation of compositions for metered-dose aerosol.
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
EP0373499A3 (en) Antiperspirant and deodorant
PL330763A1 (en) Insulin preparations containing nacl
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
ZA915932B (en) (2r)-2-(di(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use
ES2089357T3 (es) Formulacion medicinal en forma de aerosol.
ES2060293T3 (es) Nueva sustancia antiulcerosa.
ZA892568B (en) Use of perfluoropolyethers in the form of an aqueous microemulsion for protecting stony materials from atmospheric agents
FI923088A (fi) Oktadekyl-(2-(n-metylpiperidino)-etyl)-fosfat och foerfarande foer dess framstaellning
ES2131482A1 (es) Formulacion acuosa de bambuterol.
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
FI920222A0 (fi) Doseringsmedel innefattande en jonofor.
WO1991013606A3 (de) Verwendung von 3,7-dimethyloctan-1-ol in kosmetischen und dermatologischen präparaten
GB2162746A (en) Antiacidotic medicinal agent
IT1240352B (it) Formulazioni liposomiali di farmaci mucosecretolitici e/o broncopolmonari per applicazione aerosolica
ES1015889Y (es) Mascarilla para uso medico-quirurgico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 536250

Country of ref document: ES